Therapeutic radiopharmaceuticals in oncology, pediatric nuclear medicine
Engineering driven medicine, Y-90 microsphere therapy for liver cancers, imaging in sarcoma, pulmonary embolism, infection imaging.
Renee M. Moadel, MD, MSc, is an Attending Physician in the Department of Radiology and an Assistant Professor of Nuclear Medicine and Medicine at our Albert Einstein College of Medicine. Dr. Moadel has been with Montefiore since 2002, with a clinical focus on therapeutic radiopharmaceuticals in oncology and pediatric nuclear medicine, and a particular interest in the therapy of thyroid, liver, and prostate cancers.
Dr. Moadel received her Doctor of Medicine in 1996 and Master of Clinical Research in 2007 at our Albert Einstein College of Medicine. From 1996 to 2001, Dr. Moadel completed her postgraduate training with a residency in medicine and nuclear medicine, a chief residency in nuclear medicine, and a fellowship in nuclear medicine at our Albert Einstein College of Medicine.
In addition to sarcoma, pulmonary embolism, and infection imaging, Dr. Moadel’s research focuses on engineering-driven medicine and the use of Y-90 microsphere therapy (a minimally evasive procedure combining embolization and radiation) for treating liver cancers. Her research examines many topics, ranging from nuclear therapy of breast cancer to methods of body scanning. Dr. Moadel’s work has been published in a number of reviewed journals, books, and review articles.
In 1998, Dr. Moadel was the recipient of the Leo M. Davidoff Society Award for Teaching in Internal Medicine by Montefiore, which honors teachers who have made significant contributions to the education of students of our Albert Einstein College of Medicine.
She is board certified by the American College of Nuclear Medicine, sitting on the Board of Regents.